Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling.
Novel Quantification of Extracellular Vesicles with Unaltered Surface Membranes Using an Internalized Oligonucleotide Tracer and Applied Pharmacokinetic Multiple Compartment Modeling.
复制标题
DOI:
10.1007/s11095-021-03102-z
复制
发表时间:
2021-10
影响因子:
3.7
通讯作者:
Benson EA
中科院分区:
文献类型:
--
作者:
De Luca T;Stratford RE Jr;Edwards ME;Ferreira CR;Benson EA
We developed an accessible method for labeling small extracellular vesicles (sEVs) without disrupting endogenous ligands. Using labeled sEVs administered to conscious rats, we developed a multiple compartment pharmacokinetic model to identify potential differences in the disposition of sEVs from three different cell types. Crude sEVs were labeled with a non-homologous oligonucleotide and isolated from cell culture media using a commercial reagent. Jugular vein catheters were used to introduce EVs to conscious rats (n = 30) and to collect blood samples. Digital PCR was leveraged to allow for quantification over a wide dynamic range. Non-linear mixed effects analysis with first order conditional estimation – extended least squares (FOCE ELS) was used to estimate population-level parameters with associated intra-animal variability. 86.5% ± 1.5% (mean ± S.E.) of EV particles were in the 45–195 nm size range and demonstrated protein and lipid markers of endosomal origin. Incorporated oligonucleotide was stable in blood and detectable over five half-lives. Data were best described by a three-compartment model with one elimination from the central compartment. We performed an observation-based simulated posterior predictive evaluation with prediction-corrected visual predictive check. Covariate and bootstrap analyses identified cell type having an influence on peripheral volumes (V2 and V3) and clearance (Cl3). Our method relies upon established laboratory techniques, can be tailored to a variety of biological questions regarding the pharmacokinetic disposition of extracellular vesicles, and will provide a complementary approach for the of study EV ligand-receptor interactions in the context of EV uptake and targeted therapeutics. The online version contains supplementary material available at 10.1007/s11095-021-03102-z.
登录
查看更多内容
影响因子:
4.6
作者:
Patel, Girijesh Kumar;Khan, Mohammad Aslam;Singh, Ajay Pratap
通讯作者:
Singh, Ajay Pratap
影响因子:
4.4
作者:
Dipali, Shweta S.;Ferreira, Christina R.;Duncan, Francesca E.
通讯作者:
Duncan, Francesca E.
影响因子:
15
作者:
Li, YF;Breaker, RR
通讯作者:
Breaker, RR
影响因子:
11.2
作者:
Grange, Cristina;Tapparo, Marta;Camussi, Giovanni
通讯作者:
Camussi, Giovanni
影响因子:
16
作者:
Karttunen, Jenni;Heiskanen, Mette;Pitkanen, Asla
通讯作者:
Pitkanen, Asla